Industry Indices
← Research Library

AO RESEARCH · 2026.10.03

Industry research & source archive

Explore statistics, financial evidence, events, participation surveys, procurement and venue services, with original dates, units, regions and any scope that still needs confirmation.

Evidence counts do not represent new products, legal entities or accepted index samples. Source publication, scoring and image approvals remain unchanged.

Research briefs & report

Aquatic timing documents: equipment and system boundariesChinese original with English abstractResearch text & scope →Road running and marathon cohorts: public-source boundaries, 2024–2025Chinese original with English abstractResearch text & scope →Public-source comparison groups, 3 October 2026Chinese original with English abstractResearch text & scope →Three equipment issuers: disclosures for 2024–2025Chinese original with English abstractResearch text & scope →Three 2025 marathons: events, actor roles and project locationsChinese original with English abstractResearch text & scope →Sports-industry source research: English abstractEnglish abstract (not a full translation)Research text & scope →China sports-industry and sports-ground time series: English abstractEnglish abstract (not a full translation)Research text & scope →National sports-ground releases, 2019–2024: English abstractEnglish abstract (not a full translation)Research text & scope →National sports-industry and sports-ground annual source seriesChinese originalResearch text & scope →Public sports-facility procurement: revised sample and audit limitsChinese originalResearch text & scope →Above-size sports and recreation retail: annual fragments and revisionsChinese original with English abstractResearch text & scope →From opening plans to reported venue servicesChinese originalResearch text & scope →From opening plans to reported venue services: English abstractEnglish abstract (not a full translation)Research text & scope →
Read the industry research report →

Conditional specification research: select one identity

7 heterogeneous research identities and 70 source observations; displayed separately, without adding products or treating them as 70 homogeneous scalar parameters.

Financial Observations

100 records · 1 / 5

Source version & integrity

SHA-256 fe4e47549917b5cb1d345e31653743d2adc0d4134c5ff1e1828c8097d6f65cb5

The original source version is retained for verification.

Source record 1
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
revenue_total
Reported metric
营业收入
Printed number
1,417,094,638.60
Reported unit
元(人民币)
normalization factor
1
Converted value
1417094638.60
Converted unit
CNY
display value source units
1417094638.60
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
6
Printed page
6
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2024_revised_p006.png
additional evidence
  • PDF page
    6
    Printed page
    6
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 2
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_expense
Reported metric
研发费用
Printed number
43,673,742.07
Reported unit
元(人民币)
normalization factor
1
Converted value
43673742.07
Converted unit
CNY
display value source units
43673742.07
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
24
Printed page
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF page
    24
    Printed page
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 3
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_input_total
Reported metric
研发投入合计
Printed number
43,673,742.07
Reported unit
元(人民币)
normalization factor
1
Converted value
43673742.07
Converted unit
CNY
display value source units
43673742.07
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
24
Printed page
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF page
    24
    Printed page
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Total R&D input as disclosed, not substituted from expense
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 4
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_input_capitalized
Reported metric
本期资本化研发投入
Printed number
0.00
Reported unit
元(人民币)
normalization factor
1
Converted value
0.00
Converted unit
CNY
display value source units
0.00
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
24
Printed page
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF page
    24
    Printed page
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 5
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_intensity_reported
Reported metric
研发投入总额占营业收入比例(%)
Printed number
3.08
Reported unit
%
normalization factor
0.01
Converted value
0.0308
Converted unit
ratio
display value source units
3.08
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
24
Printed page
24
access utc
2026-10-03T11:10:45.592311+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2024_revised_p024.png
additional evidence
  • PDF page
    24
    Printed page
    24
    role
    superseded original table amount agreement for curated scope only
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Issuer rounded percentage; derived ratio stored separately
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 6
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
revenue_total
Reported metric
营业收入
Printed number
1,566,259,241.04
Reported unit
元(人民币)
normalization factor
1
Converted value
1566259241.04
Converted unit
CNY
display value source units
1566259241.04
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
7
Printed page
7
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2025_p007.png
additional evidence
— Not disclosed
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 7
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_expense
Reported metric
研发费用
Printed number
53,588,214.84
Reported unit
元(人民币)
normalization factor
1
Converted value
53588214.84
Converted unit
CNY
display value source units
53588214.84
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
25
Printed page
25
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2025_p025.png
additional evidence
— Not disclosed
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 8
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_input_total
Reported metric
研发投入合计
Printed number
53,588,214.84
Reported unit
元(人民币)
normalization factor
1
Converted value
53588214.84
Converted unit
CNY
display value source units
53588214.84
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
26
Printed page
26
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2025_p026.png
additional evidence
— Not disclosed
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Total R&D input as disclosed, not substituted from expense
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 9
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_input_capitalized
Reported metric
本期资本化研发投入
Printed number
0.00
Reported unit
元(人民币)
normalization factor
1
Converted value
0.00
Converted unit
CNY
display value source units
0.00
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
26
Printed page
26
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2025_p026.png
additional evidence
— Not disclosed
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 10
issuer legal name
舒华体育股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_intensity_reported
Reported metric
研发投入总额占营业收入比例(%)
Printed number
3.42
Reported unit
%
normalization factor
0.01
Converted value
0.0342
Converted unit
ratio
display value source units
3.42
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
26
Printed page
26
access utc
2026-10-03T11:08:10.246189+00:00
access window utc
— Not disclosed
evidence capture
captures/shuhua_2025_p026.png
additional evidence
— Not disclosed
restatement scope
2024 revised edition selected; 2025 revenue/R&D comparatives agree; no adjustment to these consolidated totals detected. Curated 2024 revenue, R&D and MD&A category amounts checked against the superseded original and unchanged; overall reason for revised publication not independently established.
continuing operations scope
Terminated operations marked not applicable: EQ-S001 p199; EQ-S002 p196
notes
Issuer rounded percentage; derived ratio stored separately
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 11
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
revenue_total
Reported metric
营业收入
Printed number
1,213,857,643.97
Reported unit
元(人民币)
normalization factor
1
Converted value
1213857643.97
Converted unit
CNY
display value source units
1213857643.97
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
8
Printed page
8
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— Not disclosed
evidence capture
captures/impulse_2024_p008.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 12
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_expense
Reported metric
研发费用
Printed number
52,552,467.25
Reported unit
元(人民币)
normalization factor
1
Converted value
52552467.25
Converted unit
CNY
display value source units
52552467.25
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
30
Printed page
30
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— Not disclosed
evidence capture
captures/impulse_2024_p030.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 13
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_input_total
Reported metric
研发投入金额(元)
Printed number
52,552,467.25
Reported unit
元(人民币)
normalization factor
1
Converted value
52552467.25
Converted unit
CNY
display value source units
52552467.25
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
32
Printed page
32
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— Not disclosed
evidence capture
captures/impulse_2024_p032.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Total R&D input as disclosed, not substituted from expense
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 14
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_input_capitalized
Reported metric
研发投入资本化的金额(元)
Printed number
0.00
Reported unit
元(人民币)
normalization factor
1
Converted value
0.00
Converted unit
CNY
display value source units
0.00
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
32
Printed page
32
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— Not disclosed
evidence capture
captures/impulse_2024_p032.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 15
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2024-01-01
Period end
2024-12-31
Period type
fiscal_year
Year
2024
Metric
rd_intensity_reported
Reported metric
研发投入占营业收入比例
Printed number
4.33%
Reported unit
%
normalization factor
0.01
Converted value
0.0433
Converted unit
ratio
display value source units
4.33
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
32
Printed page
32
access utc
2026-10-03T11:09:47.328225+00:00
access window utc
— Not disclosed
evidence capture
captures/impulse_2024_p032.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Issuer rounded percentage; derived ratio stored separately
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 16
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
revenue_total
Reported metric
营业收入
Printed number
1,175,906,664.10
Reported unit
元(人民币)
normalization factor
1
Converted value
1175906664.10
Converted unit
CNY
display value source units
1175906664.10
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
8
Printed page
8
access utc
— Not disclosed
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p008.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 17
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_expense
Reported metric
研发费用
Printed number
51,565,452.91
Reported unit
元(人民币)
normalization factor
1
Converted value
51565452.91
Converted unit
CNY
display value source units
51565452.91
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
28
Printed page
28
access utc
— Not disclosed
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p028.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Income statement expense; independently distinguished from total R&D input even where amounts match
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 18
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_input_total
Reported metric
研发投入金额(元)
Printed number
51,565,452.91
Reported unit
元(人民币)
normalization factor
1
Converted value
51565452.91
Converted unit
CNY
display value source units
51565452.91
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
29
Printed page
29
access utc
— Not disclosed
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p029.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Total R&D input as disclosed, not substituted from expense
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 19
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_input_capitalized
Reported metric
研发投入资本化的金额(元)
Printed number
0.00
Reported unit
元(人民币)
normalization factor
1
Converted value
0.00
Converted unit
CNY
display value source units
0.00
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
29
Printed page
29
access utc
— Not disclosed
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p029.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
— Not disclosed
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.
Source record 20
issuer legal name
青岛英派斯健康科技股份有限公司
entity scope
consolidated legal issuer group
Period start
2025-01-01
Period end
2025-12-31
Period type
fiscal_year
Year
2025
Metric
rd_intensity_reported
Reported metric
研发投入占营业收入比例
Printed number
4.39%
Reported unit
%
normalization factor
0.01
Converted value
0.0439
Converted unit
ratio
display value source units
4.39
Statistical scope
consolidated issuer
dimension
— Not disclosed
Source status
canonical
Missing-value reason
— Not disclosed
PDF page
29
Printed page
29
access utc
— Not disclosed
access window utc
  • 2026-10-03T11:00:30Z
  • 2026-10-03T11:03:00Z
evidence capture
captures/impulse_2025_p029.png
additional evidence
— Not disclosed
restatement scope
No retrospective adjustment/restatement selected in 2025 and 2024 main-indicator tables, both p8; 2024 monetary comparatives match.
continuing operations scope
Terminated-operation table blank in EQ-S003 p222; blank is not a numeric zero. Consolidated revenue taken as disclosed.
notes
Issuer rounded percentage; derived ratio stored separately
Eligible for formal public use
No
Eligible for formal scoring
No
latest Mac597 dedup status
pending current ledger absent
v3 exact amount candidates
— Not disclosed
v3 fact status
new financial observation not in v3 structured claims
v3 fact check note
Checked fixed v3 structured candidate JSON; same document already counted as source does not mean financial fact was already extracted. Low-information zeros/ratios checked by issuer/period/metric context, not token matching.